OSR Holdings

OSR Holdings is a global healthcare company that develops and licenses its pipeline of innovative biomedical therapies based on proprietary platform technology, leveraging its international network of partners in the United States, Europe, and South Korea, with the ultimate goal of addressing unmet medical needs. OSR Holdings currently owns three operational subsidiaries in Switzerland and South Korea. Two of these subsidiaries focus on developing treatments in the fields of oncology and osteoarthritis, while the third is a distributor of medical devices for treating neurovascular and other conditions.